TOP TIERMARKET NEWSWIRE
News & sentiment

OLEMA PHARMACEUTICAL (OLMA) — News & AI sentiment

OLEMA PHARMACEUTICAL (OLMA) news roundup. 9 stories aggregated over the last 30 days. Average 30-day sentiment is 45.8/100. Recent insider activity (SEC Form 4, 90-day window): 0 purchases totalling $0 and 1 sales totalling $291K — net selling of $291K. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →
24h stories
0
7d stories
0
30d stories
9
avg sentiment 45.8/100
Insider net (90d)
$291K
0 buys · 1 sells
Congress (90d)
0
0 buys · 0 sells

OLMA news in the last 24 hours, 7 days, 30 days and 90 days

How much OLMA coverage the wire captured in each window, with the average AI sentiment across those stories. Counts are of stories that have cleared the 4-hour public delay.

Time windowOLMA storiesAvg AI sentimentRead
Last 24 hours0—no coverage
Last 7 days0—no coverage
Last 30 days945.8/100OLMA headlines →
Last 90 days1746.9/100OLMA headlines →

Latest stories on OLMA

Sep 15
Sep 14
Sep 14
Stifel cuts Olema Pharmaceuticals price target on trial concerns
Investing.com Analyst Ratings34 · bearishanalyst
Sep 14
Why is Olema Pharmaceuticals stock sliding today?
Investing.com Markets34 · bearishgeneral
Sep 14
Sep 10
Sep 9
Aug 31
Aug 31
Olema Oncology names Jason O’Byrne as CFO
Seeking Alpha56 · neutralgeneral
Aug 13
Aug 13
Aug 13
Aug 13
Aug 11
Aug 10
Aug 10
Jul 2
Jun 23
Jun 23
Jun 17
Jun 10
Jun 2
May 26
May 26
May 21
Open OLMA in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →